• Accueil >
  • Publications >
  • Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models

Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models

1 oct. 2017European Radiology

DOI : 10.1007/s00330-017-4792-1

Auteurs

Nirmitha I. Herath, Flavien Devun, Aurélie Herbette, Marie-Christine Lienafa, Philippe Chouteau, Jian-Sheng Sun, Marie Dutreix, Alban Denys